foto

Dr. D.H. van Raalte MD

Main activities
Patient care, Research, Teaching
Key publications
  • Muskiet MHA, Tonneijck L, Smits MM, van Baar MJB, Kramer MHH, Hoorn EJ, Joles JA, van Raalte DH, GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes. NAT REV NEPHROL 2017;13 (10):605-628 [PubMed]
  • van Raalte DH, Verchere CB, Glucagon-Like Peptide-1 Receptor Agonists: Beta-Cell Protection or Exhaustion?. TRENDS ENDOCRIN MET 2016;27 (7):442-445 [PubMed]
  • Muskiet MHA, Tonneijck L, Smits MM, Kramer MHH, Diamant M, Joles JA, van Raalte DH, Acute renal haemodynamic effects of glucagon-like peptide-1 receptor agonist exenatide in healthy overweight men. DIABETES OBES METAB 2016;18 (2):178-185 [PubMed]
  • van Raalte DH, Bunck MC, Smits MM, Hoekstra T, Cornér A, Diamant M, Eliasson B, Taskinen MR, Heine RJ, Smith U, Yki-Järvinen H, Mari A, Exenatide improves β-cell function up to 3 years of treatment in patients with type 2 diabetes: a randomised controlled trial. EUR J ENDOCRINOL 2016;175 (4):345-352 [PubMed]
  • Tonneijck L, Smits MM, Muskiet MHA, Hoekstra T, Kramer MHH, Danser AHJ, ter Wee PM, Diamant M, Joles JA, van Raalte DH, Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. DIABETES CARE 2016;39 (11):2042-2050 [PubMed]
All Publications
Research programmes

1) islet-cell dysfunction in type1/2 diabetes 2) diabetic nephropathy/renal physiology in type 1/2 diabetes

Faculty
Dr. D.H. van Raalte MD (VU University Medical Center)

Postdocs
Dr. M.M. Smits MD (Amstelland Ziekenhuis)

PhD Students
Drs. M.J.B. van Baar MD (VUMC)
Drs. G.J. Bakker MD (DOCTOR)
E.J.M. van Bommel MD (VUmc)
Drs. A. Brouwer MD (VUMC)
Drs. J. Habibe (VUMC)
Drs. M.H.A. Muskiet MD (VUMC)
Drs. C. Racca MD (VUMC)
Drs. T.P. Scheithauer MSc (VUMC)
Drs. R. Scholtes MD (VUMC)
Drs. L. Tonneijck MD (VUMC)